Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.0B | 969.9M | 1.1B | 1.2B |
Cost of revenue | 915.6M | 837.0M | 1.0B | 1.1B |
Gross profit | 107.1M | 133.0M | 113.9M | 136.9M |
Operating expense | ||||
Research & development | 3.2M | 5.9M | 4.4M | 4.0M |
Selling general and admin | 28.2M | -82.2M | 96.9M | -27.7M |
Other operating expenses | 5.6M | 7.0M | 4.8M | 6.4M |
Operating income | 70.2M | 105.0M | 67.0M | 97.8M |
Non operating interest income | ||||
Income | 2.2M | 4.4M | 4.5M | 2.3M |
Expense | 1.9M | 4.0M | 18.6M | -2.5M |
Other income expense | — | — | — | — |
Pretax income | 72.5M | 82.6M | 53.3M | 87.5M |
Tax provision | 1.4M | 2.9M | 1.1M | 2.1M |
Net income | 71.0M | 79.7M | 52.2M | 85.4M |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 501.9M | — | — | — |
Diluted average shares | 501.9M | — | — | — |
EBITDA | 71.0M | 118.6M | 83.6M | 82.1M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |